ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2025
Pre-treatment with caffeic acid-phthalimide prevents UVB-induced oxidative stress and cytotoxicity.
Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prolonged exposure to Ultraviolet B (UVB) rays increases oxidative stress, causes direct DNA photolesions-particularly cyclobutane pyrimidine dimers (CPDs) and pyrimidine (6-4) pyrimidone photoproducts (6-4PPs)-and activates aging-related signaling pathways, leading to skin photoaging and an increased risk of skin cancer. UVB triggers a cascade of enzymatic reactions, notably through nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase), perpetuating the production of reactive oxygen species (ROS) even after exposure has ceased. While numerous studies have explored antioxidant compounds in ameliorating UVB-induced damage, caffeic acid-phthalimide (CF) stands out not only for its antioxidant potential but also for its hydrophobic nature, UVB absorption capacity, particularly within the range of 300-350 nm, and its ability to inhibit NADPH oxidase 2 (NOX2), a key enzyme in oxidative stress. This dual action-physicochemical absorption of UVB and intracellular antioxidant activity-supports CF's photoprotective potential. Therefore, we investigated the effects and potential mechanisms of CF action on L-929 fibroblasts in response to UVB-induced oxidatively generated damage. Our investigations demonstrated CF's notable antioxidant activity, as evidenced by results from both the 2,2-diphenyl-1-picrylhydrazyl (DPPH•) and xanthine oxidase (XO) assays. Notably, CF improved the viability of UVB-irradiated L-929 cells and exhibited no cytotoxicity in non-irradiated fibroblasts. CF effectively reduced ROS generation and restored the antioxidant defense system in UVB-irradiated L-929 fibroblasts. Furthermore, CF pre-treatment prevented lipid peroxidation, mitochondrial membrane depolarization, and reduced DNA condensation and apoptosis induced by UVB exposure. CF prevented cell membrane disruption and enhanced the migratory capacity of L-929 fibroblasts. Our study indicates that integrating CF into topical delivery systems holds significant promise as a strategy to counteract UVB-induced oxidatively generated damage in L-929 fibroblasts.
Indexed as
Identifiers
41186847What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.